Skip to main content

Specialties

Myelofibrosis

News
More
GLI1 Activates Pro-Fibrotic Pathways in Myelofibrosis Fibrocytes
Cell Death & Disease
1m ago
Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis
Cancers
1m ago
Patient-Specific Comorbidities as Prognostic Variables for Survival in Myelofibrosis
Blood Advances
2m ago
Diabetes and Second Neoplasia Impact on Prognosis in Pre-Fibrotic Primary Myelofibrosis
Cancers
2m ago
Response to Oxidative Damage Linked With Driver Mutations and Clinical Outcomes in Patients With Myelofibrosis
Hematology Advisor
3m ago
CAMK2G is Identified as a Novel Therapeutic Target for Myelofibrosis
Blood Advances
3m ago
FDA Approves First Drug for Myelofibrosis With Thrombocytopenia
Medscape
3m ago
Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy
ASCO: Journal of Clinical Oncology: Table of Contents
4m ago
Pevonedistat Targets Malignant Cells in Myeloproliferative Neoplasms in vitro and in vivo via NFκB Pathway Inhibition
Blood Advances
5m ago
TV
More
Radio
More
Aggrego Oncology - 3/03/22
Aggrego Oncology
3m ago
Play
More

Footer branding


Footer main navigation

  • About Us
  • Contact Us
  • Privacy Policy
  • Sign in

HMP Global Products

  • HMP Global Learning Network
  • Consultant360
  • VRTX

Copyright branding

© 2022 HMP Global. Aggrego is a trademark of HMP Global. All Rights Reserved.

<!-- BEGIN ADVERTSERVE CODE -->
<div id="mobile_block_ad_1"><script type="text/javascript">
var _avp = _avp || [];
_avp.push({ tagid: 'mobile_block_ad_1', alias: '/', type: 'banner', zid: 1669, pid: 0, onscroll: 0, inview: true, secure: true });
</script></div>
<!-- END ADVERTSERVE CODE -->

Home

Site branding - mobile

Upper navigation

  • Today
    Today
  • Following
    Following
  • Specialties
    Specialties

Main navigation

  • News
    news
  • TV
    TV
  • Radio
    Radio
  • Conference Hub
    Conf hub

User imageSign in

Register

Additional navigation- 1

  • Acute Basal Cell Carcinoma
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • AML+CLL
  • Breast Cancer
  • CAR-T Cell Therapy
  • Chronic ITP
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Cutaneous Squamous-Cell Carcinoma
  • Diffuse Large B-Cell Lymphoma
  • Early Breast Cancer
  • FDA Approvals
  • Febrile Neutropenia
  • Follicular Lymphoma
  • Gastrointestinal Cancer
  • Genitourinary Cancer
  • Graft Versus Host Disease
  • Gynecologic Cancer
  • Head And Neck Cancer
  • Healthcare Policy
  • Hematologic Malignancies
  • HER2 Low mBC
  • Immuno Oncology

Additional navigation- 2

  • Liver Cancer
  • Lung Cancer
  • Marginal Zone Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myelofibrosis
  • Non-Small-Cell Lung Cancer
  • Oncology Nursing
  • Ovarian Cancer
  • Pancreatic Cancer
  • Pediatric Oncology
  • Prostate Cancer
  • Radiation Oncology
  • Renal Cell Carcinoma
  • RET+ Advanced Thyroid Cancer
  • RET+ NSCLC
  • Sarcoma
  • Skin Cancer
  • Solid Tumors
  • Supportive Care
  • Surgical Cancer
  • Urethral Carcinoma